Abstract
The invention relates to methods for phenotyping by determining protein activity in vivo using at least one probe compound and enhancing the nuclear polarisation of NMR active nuclei present in the probe compound (hereinafter termed "hyperpolarisation") prior to NMR analysis.
Original language | English |
---|---|
IPC | G01R 33/ 465 A I |
Patent number | US2005232864 |
Filing date | 13/05/2005 |
Country/Territory | United States |
Priority date | 15/04/2003 |
Priority number | WO2003NO00126 |
Publication status | Published - 20 Oct 2005 |
Externally published | Yes |